PROPANC BIOPHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2012
Total Assets: $46.3K
Liabilities Breakdown FY2012
Total Liabilities: $584.2K
Asset Breakdown
Total Assets: $46.3K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $179 | 0.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.6K | 10.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $41.5K | 89.6% |
Liabilities Breakdown
Total Liabilities: $584.2K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $192.5K | 32.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $391.7K | 67.1% |